Clinical Trials Directory

Trials / Completed

CompletedNCT05912868

Endoscopic Mini/Less Open Sublay(EMILOS) Repair

Long-term Results in 174 Patients With a Ventral Hernia in the Midline of the Abdominal Wall After EMILOS (Endoscopic Mini/Less Open Sublay) Repair

Status
Completed
Phase
Study type
Observational
Enrollment
174 (actual)
Sponsor
Diakonie-Klinikum Stuttgart · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ventral hernias in the midline of the abdominal wall are one of the most frequent diseases in general and visceral surgery worldwide. The optimal operative technique is still in discussion. The traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Detailed description

Long-term results in 174 patients with a ventral hernia of the abdominal wall after EMILOS (Endoscopic Mini/Less Open Sublay) repair. The worldwide most frequently used surgical techniques to repair ventral abdominal wall hernias are the open sublay operation and the transabdominal IPOM (Intra-Peritoneal Onlay Mesh) technique. Therefore a special questionnaire was developed to send to the patients to evaluate long-term outcome.

Conditions

Interventions

TypeNameDescription
DEVICEEndoscopic Mini/Less Open Sublay RepairThe traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Timeline

Start date
2015-06-25
Primary completion
2021-01-27
Completion
2022-12-31
First posted
2023-06-22
Last updated
2023-06-22

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT05912868. Inclusion in this directory is not an endorsement.